Sothema engages in the manufacture of pharmaceutical and dental care products. It operates through the following activities: Importation, Exportation, Licensed Manufacturing, and Shaping. The Importation activity covers the importation of medicines, dental products, and biotechnological products. The Exportation activity exports products towards Europe, Maghreb, Sub-Saharan Africa, and the Persian Gulf. The Licensed Manufacturing activity involves in the production of licensed medicines and medicines under other labels purchased from the principal laboratories. The Shaping activity comprises of the fabrication of different pharmaceutical forms like cephalosporin, injectable ampoules, and auto-injectable syringes. The company was founded by Omar Tazi on January 26, 1976 and is headquartered in Casablanca, Morocco.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company